- Home
- ONEG vs RLYB Comparison
ONEG vs RLYB Comparison
Compare ONEG & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- RLYB
- Stock Information
- Founded
- ONEG 2021
- RLYB 2018
- Country
- ONEG Hong Kong
- RLYB United States
- Employees
- ONEG N/A
- RLYB N/A
- Industry
- ONEG Homebuilding
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- ONEG Consumer Discretionary
- RLYB Health Care
- Exchange
- ONEG Nasdaq
- RLYB Nasdaq
- Market Cap
- ONEG 22.5M
- RLYB 25.0M
- IPO Year
- ONEG 2024
- RLYB 2021
- Fundamental
- Price
- ONEG $1.97
- RLYB $0.25
- Analyst Decision
- ONEG
- RLYB Hold
- Analyst Count
- ONEG 0
- RLYB 5
- Target Price
- ONEG N/A
- RLYB $11.50
- AVG Volume (30 Days)
- ONEG 51.4K
- RLYB 194.2K
- Earning Date
- ONEG 01-01-0001
- RLYB 05-08-2025
- Dividend Yield
- ONEG N/A
- RLYB N/A
- EPS Growth
- ONEG N/A
- RLYB N/A
- EPS
- ONEG 0.12
- RLYB N/A
- Revenue
- ONEG $60,903,000.00
- RLYB $636,000.00
- Revenue This Year
- ONEG N/A
- RLYB N/A
- Revenue Next Year
- ONEG N/A
- RLYB N/A
- P/E Ratio
- ONEG $15.79
- RLYB N/A
- Revenue Growth
- ONEG 16.46
- RLYB N/A
- 52 Week Low
- ONEG $1.48
- RLYB $0.22
- 52 Week High
- ONEG $4.05
- RLYB $2.00
- Technical
- Relative Strength Index (RSI)
- ONEG N/A
- RLYB 22.80
- Support Level
- ONEG N/A
- RLYB $0.24
- Resistance Level
- ONEG N/A
- RLYB $0.28
- Average True Range (ATR)
- ONEG 0.00
- RLYB 0.06
- MACD
- ONEG 0.00
- RLYB -0.02
- Stochastic Oscillator
- ONEG 0.00
- RLYB 6.12
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.